CrystalsFirst logo

CrystalsFirst

Turning Insights Into Medicines

18 employees · est. 2018 · Hamburg, Germany

VS
iktos logo

iktos

Artificial intelligence for new drug design

85 employees · est. 2016 · Paris, France

iktos is the older company (2018 vs 2016); iktos is the larger of the two.

Side-by-Side Comparison

CrystalsFirst iktos
Founded
2018 2016 older
Headquarters
Hamburg, Germany Paris, France
Employees
18 85 larger
Industry
AI, Biotechnology, Health Care AI, Biotechnology, Health Care
Funding Stage
Non Equity Assistance Series A
Total Funding
$756.60K $18.90M
Funding Rounds
4 7
Services
Not tracked yet Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics
Target Customers
Not tracked yet Pharmaceutical Companies, Biotech Firms, Academic Institutions, Medicinal and Computational Chemists, Drug Discovery Teams
Taxonomy
Drug Discovery, Structural Biology, Computational Modelling, Generative AI, Medicinal Chemistry, Crystal Structure, Target Interactions, Rational Design, Hit Expansion, Scaffold Hopping, Compound Generation, Therapeutic Compounds, Innovative Technology, Pharmaceutical Research Drug Design, Medicinal Chemistry, Generative AI, Chemoinformatics, Robotics Automation, SaaS Software, Molecular Modeling, Oncology, Retrosynthesis, Protein-Protein Interactions, RNA-Protein Interactions, Synthesis Automation, Pharmaceutical R&D, Lead Optimization
Website
crystalsfirst.com iktos.ai
CrystalsFirst logo

About CrystalsFirst

CrystalsFirst is a biotechnology startup with the slogan "Turning Insights Into Medicines." Founded in 2018 and headquartered in Germany, the company is focused on revolutionizing small molecule drug discovery through its proprietary MAGNET platform. This technology integrates structural biology, ge...

iktos logo

About iktos

Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry. The company's...

We will tell you when either one moves

BounceWatch watches CrystalsFirst and iktos for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CrystalsFirst and iktos — by email.

Frequently Asked Questions

CrystalsFirst — Turning Insights Into Medicines. iktos — Artificial intelligence for new drug design. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CrystalsFirst has raised $756.60K while iktos has raised $18.90M.
CrystalsFirst and iktos operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CrystalsFirst with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CrystalsFirst on 12 Sep 2024, and iktos on 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy